机构:[1]Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 100864, People's Republic of China.[2]Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, United States.[3]Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, People's Republic of China.医技科室放射科首都医科大学宣武医院[4]Central Research Institute, United Imaging Healthcare Group Co., Ltd, Shanghai 201807, People's Republic of China.[5]School of Biomedical Engineering, Shanghai Tech University, Shanghai 201210, People's Republic of China.[6]United Imaging Research Institute of Innovative Medical Equipment, Shenzhen 518055, People's Republic of China.深圳市康宁医院深圳医学信息中心
Scientific Instrument Innovation
Team of the Chinese Academy of Sciences (GJJSTD20180002), the
Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province (2020B1212060051), Shenzhen Science
and Technology Innovation Committee (20220531100209020), and
Department of Science and Technology of Guangdong Province
(2022A1515110716).
第一作者机构:[1]Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 100864, People's Republic of China.
通讯作者:
通讯机构:[1]Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 100864, People's Republic of China.[6]United Imaging Research Institute of Innovative Medical Equipment, Shenzhen 518055, People's Republic of China.[*1]Xueyuan Avenue 1068, Nanshan District, Shenzhen, Guangdong, China.
推荐引用方式(GB/T 7714):
Ding Jie,Shen Chushu,Wang Zhenguo,et al.Tau-PET abnormality as a biomarker for Alzheimer's disease staging and early detection: a topological perspective[J].CEREBRAL CORTEX.2023,doi:10.1093/cercor/bhad312.
APA:
Ding Jie,Shen Chushu,Wang Zhenguo,Yang Yongfeng,El Fakhri Georges...&For the Alzheimer’s Disease Neuroimaging Initiative and the Harvard Brain Aging Study.(2023).Tau-PET abnormality as a biomarker for Alzheimer's disease staging and early detection: a topological perspective.CEREBRAL CORTEX,,
MLA:
Ding Jie,et al."Tau-PET abnormality as a biomarker for Alzheimer's disease staging and early detection: a topological perspective".CEREBRAL CORTEX .(2023)